Bright Minds Biosciences Provides Scientific Update On Its Novel 5-HT2A Psychedelic Program For The Treatment Of Mental Diseases
Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (NASDAQ:DRUG) (CSE:DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of
